Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vivace Therapeutics
Vivace Therapeutics
AACR 2023 – Hippo makes a splash
AACR 2023 – Hippo makes a splash
EP Vantage
Vivace Therapeutics
VT3989
AACR
Novartis
Sanofi
Ikena Oncology
Flag link:
AACR 2023 – Moderna's immunotherapeutic splash
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
AACR
Moderna Therapeutics
Allogene
AstraZeneca
Merck
Roche
Novartis
Eli Lilly
Innovent
Springworks
Biogene
Relay Therapeutics
Vivace Therapeutics
Flag link:
Vivace Therapeutics scores $30M Series C to take oncology candidate for 'Hippo' pathway to human trial next year
Vivace Therapeutics scores $30M Series C to take oncology candidate for 'Hippo' pathway to human trial next year
Endpoints
Vivace Therapeutics
oncology
hippo pathway
funding
Flag link:
Vivace Therapeutics Comes Out of Stealth With $25M for Cancer Drugs
Vivace Therapeutics Comes Out of Stealth With $25M for Cancer Drugs
Xconomy
Vivace Therapeutics
cancer
Flag link:
